1. Home
  2. CADL vs NPCT Comparison

CADL vs NPCT Comparison

Compare CADL & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.24

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Core Plus Impact Fund of Beneficial Interest

NPCT

Nuveen Core Plus Impact Fund of Beneficial Interest

HOLD

Current Price

$10.24

Market Cap

294.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
NPCT
Founded
1999
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
339.8M
294.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
NPCT
Price
$6.24
$10.24
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.43
N/A
AVG Volume (30 Days)
706.6K
107.1K
Earning Date
03-12-2026
01-01-0001
Dividend Yield
N/A
9.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$8.58
52 Week High
$13.68
$10.63

Technical Indicators

Market Signals
Indicator
CADL
NPCT
Relative Strength Index (RSI) 56.82 48.44
Support Level $5.88 $10.05
Resistance Level $6.62 $10.31
Average True Range (ATR) 0.38 0.07
MACD 0.03 0.01
Stochastic Oscillator 71.43 69.23

Price Performance

Historical Comparison
CADL
NPCT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest

Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.

Share on Social Networks: